VANCOUVER, April 18th, 2018 – Segra International Corp. (“Segra” or “the Company”) is pleased to announce that DNA Genetics has signed a Letter of Intent with Segra to develop a program in California regarding plant micropropagation (also known as ‘tissue culture’). According to this letter of intent, DNA Genetics and Segra will transition a set of existing DNA Genetics cannabis cultivars into tissue culture for genetic preservation and production purposes. DNA Genetics is interested in utilizing micropropagated plantlets to further optimize its production capability, preserve genetics, and reduce the pathogen risks associated with traditional cannabis nursery operations.
About DNA Genetics
DNA Genetics is a world-leading supplier of the highest quality cannabis seeds for the medicinal and recreational markets. Established over thirteen years ago in Amsterdam, DNA Genetics has developed an exceptional global cannabis brand. Winners of numerous awards at The High Times Cannabis Cup, Emerald Cup, Spannabis, Chalice, and ExpoWeed, DNA Genetics has a proven track record of driving product trends in the global marketplace.
Segra is an agricultural life sciences company that specializes in industrial-scale cannabis micropropagation. Segra is developing industrial-scale cannabis micropropagation laboratories in Canada and USA (California) to produce wholesale, disease-free, robust plantlets for nurseries, distributors, and licensed producers.
On behalf of the Board of Directors,
Todd McMurray, President/CEO
SEGRA INTERNATIONAL CORP.
This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.
For further information, contact